Tower Research Capital (TRC)’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.18K | Sell |
|
|||||
|
2025
Q2 | $3.71K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $396 | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $8.26K | Sell |
|
|||||
|
2024
Q1 | $45.4K | Buy |
|
|||||
|
2023
Q4 | $10.1K | Buy |
|
|||||
|
2023
Q3 | $5.13K | Sell |
|
|||||
|
2023
Q2 | $11.8K | Buy |
|
|||||
|
2023
Q1 | $10K | Sell |
|
|||||
|
2022
Q4 | $84K | Buy |
|
|||||
|
2022
Q3 | $32K | Sell |
|
|||||
|
2022
Q2 | $28K | Buy |
|
|||||
|
2022
Q1 | $6K | Sell |
|
|||||
|
2021
Q4 | $28K | Buy |
|
|||||
|
2021
Q3 | $18K | Sell |
|
|||||
|
2021
Q2 | $33K | Sell |
|
|||||
|
2021
Q1 | $63K | Buy |
|
|||||
|
2020
Q4 | $37K | Sell |
|
|||||
|
2020
Q3 | $462K | Buy |
|
|||||
|
2020
Q2 | $40K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $84K | Buy |
|